a public good project by the
Synthesis
Company
of California

© 2026

Magnus Nakrem Lyngbakken | doi.page

0 works0 citations0 h-index

Magnus Nakrem Lyngbakken

Oslo University Hospital(NO)University of Oslo(NO)Akershus University Hospital(NO)Levanger Hospital(NO)Trondheim Kommune(NO)

Publications by Year

Research Areas

Acute Myocardial Infarction Research, Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics, Atrial Fibrillation Management and Outcomes, Heart Failure Treatment and Management

Most-Cited Works

→ SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe(2021)1,513 cited
→ Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(2021)291 cited
→ Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium(2019)284 cited
→ Novel biomarkers of cardiovascular disease: Applications in clinical practice(2018)139 cited
→ Prognostic Value of Cardiovascular Biomarkers in the Population(2024)93 cited
→ Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study)(2018)89 cited

→ A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics(2020)79 cited

→ Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials(2020)78 cited

→ Carotid Plaque Score for Stroke and Cardiovascular Risk Prediction in a Middle‐Aged Cohort From the General Population(2023)69 cited

→ Prevalence of Carotid Plaque in a 63‐ to 65‐Year‐Old Norwegian Cohort From the General Population: The ACE (Akershus Cardiac Examination) 1950 Study(2018)46 cited